Corteva (CTVA) Wells Fargo 2024 Industrials Conference summary
Event summary combining transcript, slides, and related documents.
Wells Fargo 2024 Industrials Conference summary
1 Feb, 2026Key achievements and financial performance
Celebrated five years as a public company, adding 7,000 patents and improving EBITDA margins by over 500 basis points to 19.6% from 2019 to 2023.
Returned over $5 billion to shareholders through dividends and share buybacks since IPO.
2024 EBITDA guidance remains at $3.5–$3.7 billion, with cash flow conversion targeted at 50% of EBITDA.
First half EBITDA expected to be 80% of full year, with some shift of crop protection revenue from Q2 to Q3 due to weather delays.
Cost savings of $350–$450 million expected in 2024, driven by royalty reductions, productivity, and input cost deflation.
Market and operational updates
Strong seed business performance in the U.S., with corn and soybean planting near historic averages despite weather challenges.
Crop protection business faces demand-supply imbalances and weather-related delays in both the U.S. and Europe, shifting some sales to later quarters.
Latin America impacted by Brazil flooding and Argentina corn stunt, but effects on upcoming season remain uncertain.
U.S. corn acreage down about 5% year-over-year, soybeans up, both tracking USDA expectations.
Yield expectations remain healthy, with early indicators positive for both corn and soybeans.
Strategic initiatives and future outlook
Ongoing focus on controlling costs, with royalty expense reductions expected to make the company royalty neutral by decade's end.
Crop protection business to benefit from $150 million tailwind in input cost deflation in 2H 2024.
Seed cost benefits expected to materialize in 2025–2026, supporting margin growth.
Key drivers for 2025 margin targets include seed pricing, new hybrids, new crop protection products, and growth in the biologicals business.
Capital allocation balanced between dividends, share buybacks, and reinvestment, with $1 billion in buybacks targeted for 2024.
Latest events from Corteva
- Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.CTVA
Proxy filing19 Mar 2026 - 2025 results delivered margin growth, strong governance, and pay aligned to performance and ESG.CTVA
Proxy filing19 Mar 2026 - Strong 2025 results and resilient nitrogen markets drive growth amid global and policy shifts.CTVA
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - 2025 saw record margins, cash flow, and Bayer deal; 2026 set for further growth and separation.CTVA
Q4 20254 Feb 2026 - Seed strength and margin gains offset Crop Protection headwinds; 2024 outlook trimmed.CTVA
Q2 20242 Feb 2026 - Seed growth, cost control, and innovation drive outlook despite Argentina and weather headwinds.CTVA
BMO Ag-Apalooza Conference20 Jan 2026 - 2024 guidance narrowed as Q3 sales fell, but 2025 outlook targets strong EBITDA growth.CTVA
Q3 202415 Jan 2026 - Record 2024 margins and cash flow; 2025 targets 10% EBITDA growth and $1B buybacks.CTVA
Q4 20248 Jan 2026 - Q1 2025 operating EBITDA up 15% to $1.19B with margin gains; $1B buyback planned.CTVA
Q1 20258 Jan 2026